Drugs / follicle-stimulating hormone
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02310919 | Sep 2014 → Jun 2018 | infertility disorder | University of California, San Francisco | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | follicle-stimulating hormone | “OBJECTIVE: To assess if triggering with 1,500 IU of human chorionic gonadotropin (hCG) with 450 IU of follicle-stimulating hormone (FSH) induces noninferior oocyte competence...” PMID 35705380 ↗ Jun 2022 |
| Known as | FSH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02310919 ↗ |
| Route | Subcutaneous | “hCG 1,500 IU SQ + FSH 450 IU SQ.” NCT02310919 ↗ |